(NASDAQ: SRDX) Surmodics's forecast annual revenue growth rate of 0.44% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Surmodics's revenue in 2025 is $121,575,000.On average, 2 Wall Street analysts forecast SRDX's revenue for 2025 to be $1,675,516,494, with the lowest SRDX revenue forecast at $1,665,721,496, and the highest SRDX revenue forecast at $1,685,311,491. On average, 2 Wall Street analysts forecast SRDX's revenue for 2026 to be $1,743,866,985, with the lowest SRDX revenue forecast at $1,728,781,259, and the highest SRDX revenue forecast at $1,758,952,711.
In 2027, SRDX is forecast to generate $1,842,031,446 in revenue, with the lowest revenue forecast at $1,826,016,268 and the highest revenue forecast at $1,858,046,624.